
Matthew Solimon
Medical Liaison, MS3 at Boonshoft School of Medicine
Team
- Matthew Solimon (above)
- Michael Chetta, MD, CEO | Co-Founder
- Marcos Zachary, Master’s degree candidate, CTO | Co-Founder
- Kevin Chung, PhD, Bioengineer
Summary | Crimson Scientific
Our innovation is a wireless, reusable ECG pad with 30 dry electrodes and AI-powered algorithms, eliminating the need for skin prep, manual placement, and wires. This reduces the 10-minute average ECG capture time while ensuring accurate, standardized positioning for reliable results. By addressing inefficiencies and reducing errors common in traditional ECGs, our solution is particularly valuable in acute care and underserved settings, where timely, accurate cardiac diagnostics are critical. This innovation improves diagnostic speed, minimizes human error, and expands access to quality cardiac care in resource-limited environments.
Back to the Innovation Festival